Event JSON
{
"id": "1173cb88f172347f1dc09dc25c5f11ea132eea887fd0ea722bcfa124e7d04775",
"pubkey": "a7973ec5129a8bc7dd08825f662ab9a03318538b0ea204338b4a7ea686150246",
"created_at": 1727390999,
"kind": 1,
"tags": [
[
"d",
"bf9d385b-c06c-4fc3-beed-6e188be3fe75"
],
[
"subject",
"FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades"
],
[
"r",
"https://www.cnbc.com/2024/09/26/fda-approves-bristol-myers-squibbs-schizophrenia-drug.html"
],
[
"snaid",
"6edd3227-e00c-4e68-bc80-50c832580e7f"
],
[
"published_at",
"1727390972"
],
[
"p",
"a7973ec5129a8bc7dd08825f662ab9a03318538b0ea204338b4a7ea686150246"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/108039887-1727381992515-karxt_product_image_bottles_720.jpg?v=1727382054\u0026w=1920\u0026h=1080",
"alt Article image"
],
[
"p",
"5f7bc57f61a88f5c2728ac4576686198b2d761785d46ca59bb9af4ac31f59f91"
]
],
"content": "FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades\nhttps://image.cnbcfm.com/api/v1/image/108039887-1727381992515-karxt_product_image_bottles_720.jpg?v=1727382054\u0026w=1920\u0026h=1080\n\nThe twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.\n\nhttps://www.cnbc.com/2024/09/26/fda-approves-bristol-myers-squibbs-schizophrenia-drug.html",
"sig": "3af9fec698378f43d382ae7a8bd271a968827e8cc0690f086f6e329fe9bbd1dafa6da0e72bfe9d116f0d8bc54e91ebfa6b73cfca97e11cc469f8a98bdc7e53af"
}
